Unknown

Dataset Information

0

Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.


ABSTRACT: Inhibitory receptors mediate CD8 T-cell hyporesponsiveness against cancer and infectious diseases. PD-1 and CTLA-4 have been extensively studied, and blocking antibodies have already shown clinical benefit for cancer patients. Only little is known on extended co-expression of inhibitory receptors and their ligands. Here we analyzed the expression of eight inhibitory receptors by tumor-antigen specific CD8 T-cells. We found that the majority of effector T-cells simultaneously expressed four or more of the inhibitory receptors BTLA, TIM-3, LAG-3, KRLG-1, 2B4, CD160, PD-1 and CTLA-4. There were major differences depending on antigen-specificity, differentiation and anatomical localization of T-cells. On the other hand, naive T-cells were only single or double positive for BTLA and TIM-3. Extended co-expression is likely relevant for effector T-cells, as we found expression of multiple ligands in metastatic lesions of melanoma patients. Together, our data suggest that naive T-cells are primarily regulated by BTLA and TIM-3, whereas effector cells interact via larger numbers of inhibitory receptors. Blocking multiple inhibitory receptors simultaneously or sequentially may improve T-cell based therapies, but further studies are necessary to clarify the role of each receptor-ligand pair.

SUBMITTER: Baitsch L 

PROVIDER: S-EPMC3275569 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications


Inhibitory receptors mediate CD8 T-cell hyporesponsiveness against cancer and infectious diseases. PD-1 and CTLA-4 have been extensively studied, and blocking antibodies have already shown clinical benefit for cancer patients. Only little is known on extended co-expression of inhibitory receptors and their ligands. Here we analyzed the expression of eight inhibitory receptors by tumor-antigen specific CD8 T-cells. We found that the majority of effector T-cells simultaneously expressed four or mo  ...[more]

Similar Datasets

| S-EPMC10198502 | biostudies-literature
| S-EPMC7642207 | biostudies-literature
| S-EPMC6349966 | biostudies-literature
| S-EPMC2832619 | biostudies-literature
| S-EPMC2605166 | biostudies-literature
| S-EPMC5340255 | biostudies-literature
| S-EPMC10577604 | biostudies-literature
| S-EPMC8328067 | biostudies-literature
| S-EPMC8748927 | biostudies-literature
| S-EPMC6804740 | biostudies-literature